Filing Flows › Zomedica (ZOMDF) › Capital revenue
Zomedica (ZOMDF) Capital revenue by quarter
Zomedica's Capital revenue was $2.0M in Q3 2026 (third quarter 2026), +9% from Q2 2026. Over the last 7 quarters it ranged from $1.7M (Q2 2025) to $3.4M (Q4 2025).
| Quarter | Capital revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.0M | +9% | -9% |
| Q2 2026 | $1.8M | -7% | +11% |
| Q1 2026 | $2.0M | -43% | +0.9% |
| Q4 2025 | $3.4M | +57% | — |
| Q3 2025 | $2.2M | +33% | — |
| Q2 2025 | $1.7M | -15% | — |
| Q1 2025 | $2.0M | — | — |
Q3 2026 at a glance
Zomedica, Q3 2026: revenue $9.9M (+22% year over year), operating margin -34.6%, net loss $3.2M, operating cash flow −$2.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zomedica's Capital revenue?
Zomedica's Capital revenue was $2.0M in Q3 2026 (third quarter 2026), +9% from Q2 2026.
How has Zomedica's Capital revenue changed?
Over the last 7 quarters it ranged from $1.7M (Q2 2025) to $3.4M (Q4 2025).